CLINICAL_TRIALS
trial_result
· 2024-07-18
Clinical Trial Update: Botox for the Treatment of Recurrent Chronic Exertional Compartment Syndrome [Phase 4]
Summary
A Phase 4 trial of Botox for recurrent chronic exertional compartment syndrome of the leg was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Wisconsin, Madison | Conditions: Compartment Syndrome of Leg | Phase 4 | Status: TERMINATED | Results posted: 2024-07-18